BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 28213891)

  • 1. Opioids and the immune system - friend or foe.
    Plein LM; Rittner HL
    Br J Pharmacol; 2018 Jul; 175(14):2717-2725. PubMed ID: 28213891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of opioids on immune function in patients with cancer pain: from bench to bedside.
    Boland JW; Pockley AG
    Br J Pharmacol; 2018 Jul; 175(14):2726-2736. PubMed ID: 28593737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by opioids: Mechanisms of action on innate and adaptive immunity.
    Sun Q; Li Z; Wang Z; Wang Q; Qin F; Pan H; Lin W; Mu X; Wang Y; Jiang Y; Ji J; Lu Z
    Biochem Pharmacol; 2023 Mar; 209():115417. PubMed ID: 36682388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the mu-opioid receptor in opioid modulation of immune function.
    Ninković J; Roy S
    Amino Acids; 2013 Jul; 45(1):9-24. PubMed ID: 22170499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function.
    Boland JW; Foulds GA; Ahmedzai SH; Pockley AG
    BMJ Support Palliat Care; 2014 Dec; 4(4):357-67. PubMed ID: 24644198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects.
    López-Cano M; Font J; Aso E; Sahlholm K; Cabré G; Giraldo J; De Koninck Y; Hernando J; Llebaria A; Fernández-Dueñas V; Ciruela F
    Br J Pharmacol; 2023 Apr; 180(7):958-974. PubMed ID: 34363210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids in the immune system: from experimental studies to clinical practice.
    Moyano J; Aguirre L
    Rev Assoc Med Bras (1992); 2019 Feb; 65(2):262-269. PubMed ID: 30892453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the Risk of Infection: A Critical Appraisal of the Pharmacologic and Clinical Evidence.
    Khosrow-Khavar F; Kurteva S; Cui Y; Filion KB; Douros A
    Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):565-575. PubMed ID: 31211608
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
    Kuo A; Wyse BD; Meutermans W; Smith MT
    Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid system and human emotions.
    Nummenmaa L; Tuominen L
    Br J Pharmacol; 2018 Jul; 175(14):2737-2749. PubMed ID: 28394427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive mechanisms linking brain opioids to chronic pain vulnerability and resilience.
    Jones AKP; Brown CA
    Br J Pharmacol; 2018 Jul; 175(14):2778-2790. PubMed ID: 28449262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally acting opioids and clinical implications for pain control.
    Sehgal N; Smith HS; Manchikanti L
    Pain Physician; 2011; 14(3):249-58. PubMed ID: 21587328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression.
    Sacerdote P; Franchi S; Panerai AE
    Curr Pharm Des; 2012; 18(37):6034-42. PubMed ID: 22747543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies towards safer opioid analgesics-A review of old and upcoming targets.
    Varga BR; Streicher JM; Majumdar S
    Br J Pharmacol; 2023 Apr; 180(7):975-993. PubMed ID: 34826881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamic interaction between pain and opioid misuse.
    Wilson-Poe AR; Morón JA
    Br J Pharmacol; 2018 Jul; 175(14):2770-2777. PubMed ID: 28602044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of neuropathic pain by immune cells and opioids.
    Machelska H
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):559-70. PubMed ID: 21631408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the immune system: clinical relevance.
    Garcia JB; Cardoso MG; Dos-Santos MC
    Rev Bras Anestesiol; 2012; 62(5):709-18. PubMed ID: 22999403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.
    Zhang P; Yang M; Chen C; Liu L; Wei X; Zeng S
    Front Immunol; 2020; 11():1455. PubMed ID: 32733481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.